Erik Lipšic

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

Dirk J. Lok, Peter van der Meer, Pieta W. Bruggink‐André de la Porte et al. · Clinical Research in Cardiology · 2010 · 465 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Erythropoietin Induces Neovascularization and Improves Cardiac Function in Rats With Heart Failure After Myocardial Infarction

Peter van der Meer, Erik Lipšic, Robert H. Henning et al. · Journal of the American College of Cardiology · 2005 · 257 citations · Full text

Medicine, Cardiology, Pharmacology +13

Relationship of Arterial Stiffness Index and Pulse Pressure With Cardiovascular Disease and Mortality

M. Abdullah Said, Ruben N. Eppinga, Erik Lipšic et al. · Journal of the American Heart Association · 2018 · 231 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization

B. Daan Westenbrink, Erik Lipšic, Peter van der Meer et al. · European Heart Journal · 2007 · 221 citations · Full text

Medicine, Cardiology, Pharmacology +14

Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention

Vincent Roolvink, Borja Ibáñez, Jan Paul Ottervanger et al. · Journal of the American College of Cardiology · 2016 · 205 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16